Promote Sponsor
verified SJR 4,8 · Q1 • database Scopus / SJR & Web of Science indexed
Clinical Cancer Research
United States · American Association for Can...
workspace_premium Q1 — Oncology visibility_off Single blind Peer Review lock Subscription Unclaimed

Clinical Cancer Research

Clinical Cancer Research publishes innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. The Journal is especially interested in clinical trials evaluating new treatments, accompanied by research on pharmacology, and molecular al...

ISSN: 1078-0432
Editorial: American Association for Cancer Research Inc.
Category: Oncology
Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Visitar Portal de la Editorial menu_book Guía para Autores (Guidelines)
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
4,8 Q1
H-index 392
Tasa de Aceptación pie_chart
16% Selectiva
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
NPD
Campo Sin dato
Coste de Publicación (APC) payments
3.500 € Subscription
Ruta Non-OA 1500 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

4,8

H-index

392

Docs (year)

571

Docs 3y

1880

Total refs

23331

Cites 3y

17406

Citable 3y

1807

Cites/Doc 2y

8.53

Ref/Doc

40.86

Immediate OA

3500 €

Embargoed OA

NPD

Non OA / Submission

1500 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Circulating Tumor Cells in Patients with Testicular Germ Cell Tumors

View more

Use of [11C]Choline PET-CT as a Noninvasive Method for Detecting Pelvic Lymph Node Status from Prostate Cancer and Relationship with Choline Kinase Expression

View more

Diagnostic Evaluation of HER-2 as a Molecular Target: An Assessment of Accuracy and Reproducibility of Laboratory Testing in Large, Prospective, Randomized Clinical Trials

View more

Detection of Human Papillomavirus-16 in Fine-Needle Aspirates to Determine Tumor Origin in Patients with Metastatic Squamous Cell Carcinoma of the Head and Neck

View more

Delta-Like Ligand 4 Plays a Critical Role in Pericyte/Vascular Smooth Muscle Cell Formation during Vasculogenesis and Tumor Vessel Expansion in Ewing's Sarcoma

View more

Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer

View more

Cyclophilin A Maintains Glioma-Initiating Cell Stemness by Regulating Wnt/beta-Catenin Signaling

View more

Control of Cell Growth and Survival by Enzymes of the Fatty Acid Synthesis Pathway in HCT-116 Colon Cancer Cells

View more

Comparative Transcriptome Profiling Reveals Coding and Noncoding RNA Differences in NSCLC from African Americans and European Americans

View more

Combined Inhibition of Both p110a and p110beta Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER+ Breast Cancer

View more

Combination of Imatinib Mesylate with Autologous Leukocyte-Derived Heat Shock Protein and Chronic Myelogenous Leukemia

View more

Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy

View more
SHOW MORE ARTICLES

Class 1, 2, and 3 BRAF-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization

View more

130-nm Albumin-Bound Paclitaxel Enhances Tumor Radiocurability and Therapeutic Gain

View more

Circulating Matrix Metalloproteinase-9 Levels as a Biomarker of Disease

View more

BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen-Resistant Breast Cancer

View more

Biomarkers associated with beneficial PD-1 checkpoint blockade in non-small-cell lung cancer (NSCLC) identified using high-plex digital spatial profiling

View more

AR-Variant-Positive CTC: A Surrogate for a Surrogate for Taxane Therapy Outcome?

View more

Anti-Programmed Death-1 Synergizes with Granulocyte Macrophage Colony-Stimulating Factor-Secreting Tumor Cell Immunotherapy Providing Therapeutic Benefit to Mice with Established Tumors

View more

Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy

View more

Anti-Folate Receptor alpha-directed Antibody Therapies Restrict the Growth of Triple Negative Breast Cancer

View more

Activation of Host Wound Responses in Breast Cancer Microenvironment

View more

Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27-Dependent Pathway

View more

A Randomized Phase II Study of Concurrent Docetaxel Plus Vaccine Versus Vaccine Alone in Metastatic Androgen-Independent Prostate Cancer

View more

FAQS